Symbiosis Ip Limited patent opposition analysis

The comprehensive analysis of Symbiosis Ip Limited opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Symbiosis Ip Limited

Patent NumberTitleApplicantOpposition DateOpposition Company
Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHMEMay 26, 2022SYMBIOSIS IP LIMITED
Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 AntagonistsMERCK SHARP & DOHMESep 15, 2021SYMBIOSIS IP LIMITED

Top companies who are the clients of Symbiosis Ip Limited